Carbon monoxide and the CNS: Challenges and achievements

British Journal of Pharmacology

Volumn 172, Issue 6, 2015, Pages 1533-1545

  Queiroga, Cláudia S F ^a   Vercelli, Alessandro ^b   Vieira, Helena L A ^a,c  

^a NOVA MEDICAL SCHOOL   (Portugal)

^b UNIVERSITY OF TURIN   (Italy)

^c INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLÓGICA   (Portugal)

Author keywords

astrocytes; brain; carbon monoxide; CO releasing molecules; ischaemia; microglia; neurodegeneration; neuroinflammation; neurons; neuroprotection

Indexed keywords

CARBON MONOXIDE; CARBON MONOXIDE RELEASING MOLECULE 2; CARBON MONOXIDE RELEASING MOLECULE 3; CARBON MONOXIDE RELEASING MOLECULE A1; CARBOXYHEMOGLOBIN; CURCUMIN; EPICATECHIN; FERRITIN; GINKGO BILOBA EXTRACT; GUANYLATE CYCLASE; HEME OXYGENASE; HEME OXYGENASE 1; NITRIC OXIDE SYNTHASE; OCTREOTIDE; POTASSIUM CHANNEL; PRODRUG; REACTIVE OXYGEN METABOLITE; RESVERATROL; SEVOFLURANE; TRITERPENOID; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; BRAIN CELL; BRAIN DAMAGE; BRAIN HEMORRHAGE; BRAIN HYPOXIA; BRAIN ISCHEMIA; CELL DEATH; CELL METABOLISM; CELL PROTECTION; CENTRAL NERVOUS SYSTEM; DIAGNOSTIC VALUE; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; HUMAN; MIDDLE CEREBRAL ARTERY OCCLUSION; MULTIPLE SCLEROSIS; NERVOUS SYSTEM INFLAMMATION; NEUROPATHIC PAIN; NEUROPROTECTION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SEIZURE; SIGNAL TRANSDUCTION; TRAUMATIC BRAIN INJURY; VASODILATATION; ANIMAL; CENTRAL NERVOUS SYSTEM DISEASES; HOMEOSTASIS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; CARBON MONOXIDE; CELL DEATH; CENTRAL NERVOUS SYSTEM DISEASES; HEME OXYGENASE (DECYCLIZING); HOMEOSTASIS; HUMANS; PROGNOSIS;

EID: 84923687073     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12729     Document Type: Review

References (136)

1. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013a). The Concise Guide to PHARMACOLOGY 2013/14: Enzymes. Br J Pharmacol 170: 1797-1867.
2. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Catterall WA, et al. (2013b). The Concise Guide to PHARMACOLOGY 2013/14: Ion Channels. Br J Pharmacol 170: 1607-1651.
3. Almeida SS, Queiroga CS, Sousa MF, Alves PM, Vieira HL, (2012). Carbon monoxide modulates apoptosis by reinforcing oxidative metabolism in astrocytes: role of BCL-2. J Biol Chem 287: 10761-10770.
4. Alonso JR, Cardellach F, Lopez S, Casademont J, Miro O, (2003). Carbon monoxide specifically inhibits cytochrome c oxidase of human mitochondrial respiratory chain. Pharmacol Toxicol 93: 142-146.
5. Babu AN, Damle SS, Moore EE, Ao L, Song Y, Johnson JL, et al. (2007). Hemoglobin-based oxygen carrier induces hepatic heme oxygenase 1 expression in Kupffer cells. Surgery 142: 289-294.
6. Bani-Hani MG, Greenstein D, Mann BE, Green CJ, Motterlini R, (2006a). A carbon monoxide-releasing molecule (CORM-3) attenuates lipopolysaccharide- and interferon-gamma-induced inflammation in microglia. Pharmacol Rep 58: 132-144.
7. Bani-Hani MG, Greenstein D, Mann BE, Green CJ, Motterlini R, (2006b). Modulation of thrombin-induced neuroinflammation in BV-2 microglia by carbon monoxide-releasing molecule 3. J Pharmacol Exp Ther 318: 1315-1322.
8. Bannenberg GL, Vieira HL, (2009). Therapeutic applications of the gaseous mediators carbon monoxide and hydrogen sulfide. Expert Opin Ther Pat 19: 663-682.
9. Barone E, Di Domenico F, Sultana R, Coccia R, Mancuso C, Perluigi M, et al. (2012). Heme oxygenase-1 posttranslational modifications in the brain of subjects with Alzheimer disease and mild cognitive impairment. Free Radic Biol Med 52: 2292-2301.
10. Basuroy S, Bhattacharya S, Tcheranova D, Qu Y, Regan RF, Leffler CW, et al. (2006). HO-2 provides endogenous protection against oxidative stress and apoptosis caused by TNF-alpha in cerebral vascular endothelial cells. Am J Physiol Cell Physiol 291: C897-C908.
11. Basuroy S, Bhattacharya S, Leffler CW, Parfenova H, (2009). Nox4 NADPH oxidase mediates oxidative stress and apoptosis caused by TNF-alpha in cerebral vascular endothelial cells. Am J Physiol Cell Physiol 296: C422-C432.
12. Basuroy S, Tcheranova D, Bhattacharya S, Leffler CW, Parfenova H, (2011). Nox4 NADPH oxidase-derived reactive oxygen species, via endogenous carbon monoxide, promote survival of brain endothelial cells during TNF-alpha-induced apoptosis. Am J Physiol Cell Physiol 300: C256-C265.
13. Basuroy S, Leffler CW, Parfenova H, (2013). CORM-A1 prevents blood-brain barrier dysfunction caused by ionotropic glutamate receptor-mediated endothelial oxidative stress and apoptosis. Am J Physiol Cell Physiol 304: C1105-C1115.
14. Bernard C, (1857) Lecons sur les Effets des Substaces Toxiques et Medicamenteuses. J-B Bailliere et Fils: Paris.
15. Beschorner R, Adjodah D, Schwab JM, Mittelbronn M, Pedal I, Mattern R, et al. (2000). Long-term expression of heme oxygenase-1 (HO-1, HSP-32) following focal cerebral infarctions and traumatic brain injury in humans. Acta Neuropathol 100: 377-384.
16. Biermann J, Lagreze WA, Dimitriu C, Stoykow C, Goebel U, (2010). Preconditioning with inhalative carbon monoxide protects rat retinal ganglion cells from ischemia/reperfusion injury. Invest Ophthalmol Vis Sci 51: 3784-3791.
17. Bilban M, Haschemi A, Wegiel B, Chin BY, Wagner O, Otterbein LE, (2008). Heme oxygenase and carbon monoxide initiate homeostatic signaling. J Mol Med 86: 267-279.
18. Boczkowski J, Poderoso JJ, Motterlini R, (2006). CO-metal interaction: vital signaling from a lethal gas. Trends Biochem Sci 31: 614-621.
19. Brouard S, Otterbein LE, Anrather J, Tobiasch E, Bach FH, Choi AM, et al. (2000). Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med 192: 1015-1026.
20. Butterfield DA, Barone E, Di Domenico F, Cenini G, Sultana R, Murphy MP, et al. (2012). Atorvastatin treatment in a dog preclinical model of Alzheimer's disease leads to up-regulation of haem oxygenase-1 and is associated with reduced oxidative stress in brain. Int J Neuropsychopharmacol 15: 981-987.
21. Carvalho PG, Branco LG, Panissi CR, (2011). Involvement of the heme oxygenase-carbon monoxide-cGMP pathway in the nociception induced by acute painful stimulus in rats. Brain Res 1385: 107-113.
22. Chao XD, Ma YH, Luo P, Cao L, Lau WB, Zhao BC, et al. (2013). Up-regulation of heme oxygenase-1 attenuates brain damage after cerebral ischemia via simultaneous inhibition of superoxide production and preservation of NO bioavailability. Exp Neurol 239: 163-169.
23. Chen L, Wang L, Zhang X, Cui L, Xing Y, Dong L, et al. (2012). The protection by octreotide against experimental ischemic stroke: up-regulated transcription factor Nrf2, HO-1 and down-regulated NF-kappaB expression. Brain Res 1475: 80-87.
24. Chien WL, Lee TR, Hung SY, Kang KH, Lee MJ, Fu WM, (2011). Impairment of oxidative stress-induced heme oxygenase-1 expression by the defect of Parkinson-related gene of PINK1. J Neurochem 117: 643-653.
25. Chin BY, Jiang G, Wegiel B, Wang HJ, Macdonald T, Zhang XC, et al. (2007). Hypoxia-inducible factor 1alpha stabilization by carbon monoxide results in cytoprotective preconditioning. Proc Natl Acad Sci U S A 104: 5109-5114.
26. Chora AA, Fontoura P, Cunha A, Pais TF, Cardoso S, Ho PP, et al. (2007). Heme oxygenase-1 and carbon monoxide suppress autoimmune neuroinflammation. J Clin Invest 117: 438-447.
27. Chu PW, Beart PM, Jones NM, (2010). Preconditioning protects against oxidative injury involving hypoxia-inducible factor-1 and vascular endothelial growth factor in cultured astrocytes. Eur J Pharmacol 633: 24-32.
28. Clark JE, Naughton P, Shurey S, Green CJ, Johnson TR, Mann BE, et al. (2003). Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule. Circ Res 93: e2-e8.
29. Cousar JL, Lai Y, Marco CD, Bayir H, Adelson PD, Janesko-Feldman KL, et al. (2006). Heme oxygenase 1 in cerebrospinal fluid from infants and children after severe traumatic brain injury. Dev Neurosci 28: 342-347.
30. D'Amico G, Lam F, Hagen T, Moncada S, (2006). Inhibition of cellular respiration by endogenously produced carbon monoxide. J Cell Sci 119: 2291-2298.
31. Dirnagl U, Becker K, Meisel A, (2009). Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use. Lancet Neurol 8: 398-412.
32. Dore S, (2002). Decreased activity of the antioxidant heme oxygenase enzyme: implications in ischemia and in Alzheimer's disease. Free Radic Biol Med 32: 1276-1282.
33. Fagone P, Mangano K, Quattrocchi C, Motterlini R, Di Marco R, Magro G, et al. (2011). Prevention of clinical and histological signs of proteolipid protein (PLP)-induced experimental allergic encephalomyelitis (EAE) in mice by the water-soluble carbon monoxide-releasing molecule (CORM)-A1. Clin Exp Immunol 163: 368-374.
34. Fagone P, Mangano K, Coco M, Perciavalle V, Garotta G, Romao CC, et al. (2012). Therapeutic potential of carbon monoxide in multiple sclerosis. Clin Exp Immunol 167: 179-187.
35. Fagone P, Patti F, Mangano K, Mammana S, Coco M, Touil-Boukoffa C, et al. (2013). Heme oxygenase-1 expression in peripheral blood mononuclear cells correlates with disease activity in multiple sclerosis. J Neuroimmunol 261: 82-86.
36. Gong P, Cederbaum AI, Nieto N, (2004). Heme oxygenase-1 protects HepG2 cells against cytochrome P450 2E1-dependent toxicity. Free Radic Biol Med 36: 307-318.
37. Gozzelino R, Jeney V, Soares MP, (2010). Mechanisms of cell protection by heme oxygenase-1. Annu Rev Pharmacol Toxicol 50: 323-354.
38. Grochot-Przeczek A, Dulak J, Jozkowicz A, (2012). Haem oxygenase-1: non-canonical roles in physiology and pathology. Clin Sci (Lond) 122: 93-103.
39. Guo Y, Stein AB, Wu WJ, Tan W, Zhu X, Li QH, et al. (2004). Administration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivo. Am J Physiol Heart Circ Physiol 286: H1649-H1653.
40. Haldane J, (1895). The action of carbonic oxide on man. J Physiol 18: 430-462.
41. Harbin TJ, Benignus VA, Muller KE, Barton CN, (1988). The effects of low-level carbon monoxide exposure upon evoked cortical potentials in young and elderly men. Neurotoxicol Teratol 10: 93-100.
42. Hervera A, Leanez S, Negrete R, Motterlini R, Pol O, (2012). Carbon monoxide reduces neuropathic pain and spinal microglial activation by inhibiting nitric oxide synthesis in mice. PLoS ONE 7: e43693.
43. Hervera A, Gou G, Leanez S, Pol O, (2013a). Effects of treatment with a carbon monoxide-releasing molecule and a heme oxygenase 1 inducer in the antinociceptive effects of morphine in different models of acute and chronic pain in mice. Psychopharmacology (Berl) 228: 463-477.
44. Hervera A, Leanez S, Motterlini R, Pol O, (2013b). Treatment with carbon monoxide-releasing molecules and an HO-1 inducer enhances the effects and expression of micro-opioid receptors during neuropathic pain. Anesthesiology 118: 1180-1197.
45. Huang JY, Chuang JI, (2010). Fibroblast growth factor 9 upregulates heme oxygenase-1 and gamma-glutamylcysteine synthetase expression to protect neurons from 1-methyl-4-phenylpyridinium toxicity. Free Radic Biol Med 49: 1099-1108.
46. Hui Y, Wang D, Li W, Zhang L, Jin J, Ma N, et al. (2011). Long-term overexpression of heme oxygenase 1 promotes tau aggregation in mouse brain by inducing tau phosphorylation. J Alzheimers Dis 26: 299-313.
47. Hung SY, Liou HC, Kang KH, Wu RM, Wen CC, Fu WM, (2008). Overexpression of heme oxygenase-1 protects dopaminergic neurons against 1-methyl-4-phenylpyridinium-induced neurotoxicity. Mol Pharmacol 74: 1564-1575.
48. Imuta N, Hori O, Kitao Y, Tabata Y, Yoshimoto T, Matsuyama T, et al. (2007). Hypoxia-mediated induction of heme oxygenase type I and carbon monoxide release from astrocytes protects nearby cerebral neurons from hypoxia-mediated apoptosis. Antioxid Redox Signal 9: 543-552.
49. Innamorato NG, Rojo AI, Garcia-Yague AJ, Yamamoto M, De Ceballos ML, Cuadrado A, (2008). The transcription factor Nrf2 is a therapeutic target against brain inflammation. J Immunol 181: 680-689.
50. Innamorato NG, Jazwa A, Rojo AI, Garcia C, Fernandez-Ruiz J, Grochot-Przeczek A, et al. (2010). Different susceptibility to the Parkinson's toxin MPTP in mice lacking the redox master regulator Nrf2 or its target gene heme oxygenase-1. PLoS ONE 5: e11838.
51. 2+-activated K+ channels. Circ Res 97: 805-812.
52. Kurauchi Y, Hisatsune A, Isohama Y, Katsuki H, (2009). Nitric oxide-cyclic GMP signaling pathway limits inflammatory degeneration of midbrain dopaminergic neurons: cell type-specific regulation of heme oxygenase-1 expression. Neuroscience 158: 856-866.
53. Laudenbach V, Fontaine RH, Medja F, Carmeliet P, Hicklin DJ, Gallego J, et al. (2007). Neonatal hypoxic preconditioning involves vascular endothelial growth factor. Neurobiol Dis 26: 243-252.
54. Leffler CW, Balabanova L, Fedinec AL, Parfenova H, (2005). Nitric oxide increases carbon monoxide production by piglet cerebral microvessels. Am J Physiol Heart Circ Physiol 289: H1442-H1447.
55. Leffler CW, Parfenova H, Jaggar JH, (2011). Carbon monoxide as an endogenous vascular modulator. Am J Physiol Heart Circ Physiol 301: H1-H11.
56. Lehn A, Boyle R, Brown H, Airey C, Mellick G, (2012). Neuroferritinopathy. Parkinsonism Relat Disord 18: 909-915.
57. Li B, Lee DS, Jeong GS, Kim YC, (2012). Involvement of heme oxygenase-1 induction in the cytoprotective and immunomodulatory activities of 6,4-dihydroxy-7-methoxyflavanone in murine hippocampal and microglia cells. Eur J Pharmacol 674: 153-162.
58. Lin SX, Lisi L, Dello Russo C, Polak PE, Sharp A, Weinberg G, et al. (2011). The anti-inflammatory effects of dimethyl fumarate in astrocytes involve glutathione and haem oxygenase-1. ASN Neuro 3: 75-84.
59. Liu Y, Zhu B, Luo L, Li P, Paty DW, Cynader MS, (2001). Heme oxygenase-1 plays an important protective role in experimental autoimmune encephalomyelitis. Neuroreport 12: 1841-1845.
60. Lo Iacono L, Boczkowski J, Zini R, Salouage I, Berdeaux A, Motterlini R, et al. (2011). A carbon monoxide-releasing molecule (CORM-3) uncouples mitochondrial respiration and modulates the production of reactive oxygen species. Free Radic Biol Med 50: 1556-1564.
61. Maes OC, Kravitz S, Mawal Y, Su H, Liberman A, Mehindate K, et al. (2006). Characterization of alpha1-antitrypsin as a heme oxygenase-1 suppressor in Alzheimer plasma. Neurobiol Dis 24: 89-100.
62. Mahan VL, Zurakowski D, Otterbein LE, Pigula FA, (2012). Inhaled carbon monoxide provides cerebral cytoprotection in pigs. PLoS ONE 7: e41982.
63. Marques AR, Kromer L, Gallo DJ, Penacho N, Rodrigues SS, Seixas JD, et al. (2012). Generation of carbon monoxide releasing molecules (CO-RMs) as drug candidates for the treatment of acute liver injury: targeting of CO-RMs to the liver. Organometallics 31: 5810-5822.
64. McCoubrey WK Jr, Huang TJ, Maines MD, (1997). Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. Eur J Biochem 247: 725-732.
65. Mehindate K, Sahlas DJ, Frankel D, Mawal Y, Liberman A, Corcos J, et al. (2001). Proinflammatory cytokines promote glial heme oxygenase-1 expression and mitochondrial iron deposition: implications for multiple sclerosis. J Neurochem 77: 1386-1395.
66. Moreira TJ, Cebere A, Cebers G, Ostenson CG, Efendic S, Liljequist S, (2007). Reduced HO-1 protein expression is associated with more severe neurodegeneration after transient ischemia induced by cortical compression in diabetic Goto-Kakizaki rats. J Cereb Blood Flow Metab 27: 1710-1723.
67. Morse D, Lin L, Choi AM, Ryter SW, (2009). Heme oxygenase-1, a critical arbitrator of cell death pathways in lung injury and disease. Free Radic Biol Med 47: 1-12.
68. Motterlini R, Otterbein LE, (2010). The therapeutic potential of carbon monoxide. Nat Rev Drug Discov 9: 728-743.
69. Motterlini R, Clark JE, Foresti R, Sarathchandra P, Mann BE, Green CJ, (2002). Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities. Circ Res 90: E17-E24.
70. Motterlini R, Mann BE, Foresti R, (2005). Therapeutic applications of carbon monoxide-releasing molecules. Expert Opin Investig Drugs 14: 1305-1318.
71. Mueller C, Zhou W, Vanmeter A, Heiby M, Magaki S, Ross MM, et al. (2010). The heme degradation pathway is a promising serum biomarker source for the early detection of Alzheimer's disease. J Alzheimers Dis 19: 1081-1091.
72. Nada SE, Shah ZA, (2012). Preconditioning with Ginkgo biloba (EGb 761(R)) provides neuroprotection through HO1 and CRMP2. Neurobiol Dis 46: 180-189.
73. Nakao A, Kaczorowski DJ, Sugimoto R, Billiar TR, McCurry KR, (2008). Application of heme oxygenase-1, carbon monoxide and biliverdin for the prevention of intestinal ischemia/reperfusion injury. J Clin Biochem Nutr 42: 78-88.
74. Opii WO, Joshi G, Head E, Milgram NW, Muggenburg BA, Klein JB, et al. (2008). Proteomic identification of brain proteins in the canine model of human aging following a long-term treatment with antioxidants and a program of behavioral enrichment: relevance to Alzheimer's disease. Neurobiol Aging 29: 51-70.
75. Otterbein LE, MantelL LL, Choi AM, (1999). Carbon monoxide provides protection against hyperoxic lung injury. Am J Physiol 276: L688-L694.
76. Otterbein LE, Bach FH, Alam J, Soares M, Tao Lu H, Wysk M, et al. (2000). Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 6: 422-428.
77. Parfenova H, NEff RA 3rd, Alonso JS, Shlopov BV, Jamal CN, Sarkisova SA, et al. (2001). Cerebral vascular endothelial heme oxygenase: expression, localization, and activation by glutamate. Am J Physiol Cell Physiol 281: C1954-C1963.
78. Parfenova H, Fedinec A, Leffler CW, (2003). Ionotropic glutamate receptors in cerebral microvascular endothelium are functionally linked to heme oxygenase. J Cereb Blood Flow Metab 23: 190-197.
79. Parfenova H, Leffler CW, Basuroy S, Liu J, Fedinec AL, (2012a). Antioxidant roles of heme oxygenase, carbon monoxide, and bilirubin in cerebral circulation during seizures. J Cereb Blood Flow Metab 32: 1024-1034.
80. Parfenova H, Tcheranova D, Basuroy S, FedineC AL, Liu J, Leffler CW, (2012b). Functional role of astrocyte glutamate receptors and carbon monoxide in cerebral vasodilation response to glutamate. Am J Physiol Heart Circ Physiol 302: H2257-H2266.
81. Pena AC, Penacho N, Mancio-Silva L, Neres R, Seixas JD, Fernandes AC, et al. (2012). A novel carbon monoxide-releasing molecule fully protects mice from severe malaria. Antimicrob Agents Chemother 56: 1281-1290.
82. Piantadosi CA, (2002). Biological chemistry of carbon monoxide. Antioxid Redox Signal 4: 259-270.
83. Piantadosi CA, Carraway MS, Babiker A, Suliman HB, (2008). Heme oxygenase-1 regulates cardiac mitochondrial biogenesis via Nrf2-mediated transcriptional control of nuclear respiratory factor-1. Circ Res 103: 1232-1240.
84. Queiroga CS, Almeida AS, Martel C, Brenner C, Alves PM, Vieira HL, (2010). Glutathionylation of adenine nucleotide translocase induced by carbon monoxide prevents mitochondrial membrane permeabilization and apoptosis. J Biol Chem 285: 17077-17088.
85. Queiroga CS, Almeida AS, Vieira HL, (2012a). Carbon monoxide targeting mitochondria. Biochem Res Int 2012: 749845.
86. Queiroga CSF, Tomasi S, Widerøe M, Alves PM, Vercelli A, Veira HLA, (2012b). Preconditioning triggered by carbon monoxide (CO) provides neuronal protection following perinatal hypoxia-ischemia. PLoS ONE 7: e42632.
87. Ratan RR, Siddiq A, Aminova L, Lange PS, Langley B, Ayoub I, et al. (2004). Translation of ischemic preconditioning to the patient: prolyl hydroxylase inhibition and hypoxia inducible factor-1 as novel targets for stroke therapy. Stroke 35: 2687-2689.
88. Ren J, Fan C, Chen N, Huang J, Yang Q, (2011). Resveratrol pretreatment attenuates cerebral ischemic injury by upregulating expression of transcription factor Nrf2 and HO-1 in rats. Neurochem Res 36: 2352-2362.
89. Romao CC, Blattler WA, Seixas JD, Bernardes GJ, (2012). Developing drug molecules for therapy with carbon monoxide. Chem Soc Rev 41: 3571-3583.
90. Ruscher K, Freyer D, Karsch M, Isaev N, Megow D, Sawitzki B, et al. (2002). Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J Neurosci 22: 10291-10301.
91. Ryan MJ, Jernigan NL, Drummond HA, McLemore GR Jr, Rimoldi JM, Poreddy SR, et al. (2006). Renal vascular responses to CORM-A1 in the mouse. Pharmacol Res 54: 24-29.
92. Ryter SW, Alam J, Choi AM, (2006). Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev 86: 583-650.
93. Sakata Y, Zhuang H, Kwansa H, Koehler RC, Dore S, (2010). Resveratrol protects against experimental stroke: putative neuroprotective role of heme oxygenase 1. Exp Neurol 224: 325-329.
94. Saleem S, Zhuang H, Biswal S, Christen Y, Dore S, (2008). Ginkgo biloba extract neuroprotective action is dependent on heme oxygenase 1 in ischemic reperfusion brain injury. Stroke 39: 3389-3396.
95. Sammut IA, Foresti R, Clark JE, Exon DJ, Vesely MJ, Sarathchandra P, et al. (1998). Carbon monoxide is a major contributor to the regulation of vascular tone in aortas expressing high levels of haeme oxygenase-1. Br J Pharmacol 125: 1437-1444.
96. Savolainen H, Kurppa K, Tenhunen R, Kivisto H, (1980). Biochemical effects of carbon monoxide poisoning in rat brain with special reference to blood carboxyhemoglobin and cerebral cytochrome oxidase activity. Neurosci Lett 19: 319-323.
97. Scapagnini G, Foresti R, Calabrese V, Giuffrida Stella AM, Green CJ, Motterlini R, (2002). Caffeic acid phenethyl ester and curcumin: a novel class of heme oxygenase-1 inducers. Mol Pharmacol 61: 554-561.
98. Schallner N, Fuchs M, Schwer CI, Loop T, Buerkle H, Lagreze WA, et al. (2012). Postconditioning with inhaled carbon monoxide counteracts apoptosis and neuroinflammation in the ischemic rat retina. PLoS ONE 7: e46479.
99. Schallner N, Romao CC, Biermann J, Lagreze WA, Otterbein LE, Buerkle H, et al. (2013). Carbon monoxide abrogates ischemic insult to neuronal cells via the soluble guanylate cyclase-cGMP pathway. PLoS ONE 8: e60672.
100. Schipper HM, (2000). Heme oxygenase-1: role in brain aging and neurodegeneration. Exp Gerontol 35: 821-830.
101. Schipper HM, (2004a). Heme oxygenase-1: transducer of pathological brain iron sequestration under oxidative stress. Ann N Y Acad Sci 1012: 84-93.
102. Schipper HM, (2004b). Heme oxygenase expression in human central nervous system disorders. Free Radic Biol Med 37: 1995-2011.
103. Schipper HM, Liberman A, Stopa EG, (1998). Neural heme oxygenase-1 expression in idiopathic Parkinson's disease. Exp Neurol 150: 60-68.
104. Schipper HM, Gupta A, Szarek WA, (2009). Suppression of glial HO-1 activity as a potential neurotherapeutic intervention in AD. Curr Alzheimer Res 6: 424-430.
105. Shah ZA, Nada SE, Dore S, (2011). Heme oxygenase 1, beneficial role in permanent ischemic stroke and in Gingko biloba (EGb 761) neuroprotection. Neuroscience 180: 248-255.
106. Sjostrand T, (1949). Endogenous formation of carbon monoxide in man. Nature 164: 580.
107. Song W, Su H, Song S, Paudel HK, Schipper HM, (2006). Over-expression of heme oxygenase-1 promotes oxidative mitochondrial damage in rat astroglia. J Cell Physiol 206: 655-663.
108. Song W, Patel A, Qureshi HY, Han D, Schipper HM, Paudel HK, (2009). The Parkinson disease-associated A30P mutation stabilizes alpha-synuclein against proteasomal degradation triggered by heme oxygenase-1 over-expression in human neuroblastoma cells. J Neurochem 110: 719-733.
109. Song W, Zukor H, Lin SH, Liberman A, Tavitian A, Mui J, et al. (2012). Unregulated brain iron deposition in transgenic mice over-expressing HMOX1 in the astrocytic compartment. J Neurochem 123: 325-336.
110. Suliman HB, Carraway MS, Ali AS, Reynolds CM, Welty-Wolf KE, Piantadosi CA, (2007a). The CO/HO system reverses inhibition of mitochondrial biogenesis and prevents murine doxorubicin cardiomyopathy. J Clin Invest 117: 3730-3741.
111. Suliman HB, Carraway MS, Tatro LG, Piantadosi CA, (2007b). A new activating role for CO in cardiac mitochondrial biogenesis. J Cell Sci 120: 299-308.
112. Sutherland BA, Rahman RM, Clarkson AN, Shaw OM, Nair SM, Appleton I, (2009). Cerebral heme oxygenase 1 and 2 spatial distribution is modulated following injury from hypoxia-ischemia and middle cerebral artery occlusion in rats. Neurosci Res 65: 326-334.
113. Tang XD, Xu R, Reynolds MF, Garcia ML, Heinemann SH, Hoshi T, (2003). Haem can bind to and inhibit mammalian calcium-dependent Slo1 BK channels. Nature 425: 531-535.
114. Tenhunen R, Marver HS, Schmid R, (1968). The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci U S A 61: 748-755.
115. Thompson K, Menzies S, Muckenthaler M, Torti FM, Wood T, Torti SV, et al. (2003). Mouse brains deficient in H-ferritin have normal iron concentration but a protein profile of iron deficiency and increased evidence of oxidative stress. J Neurosci Res 71: 46-63.
116. Verma A, Hirsch DJ, Glatt CE, Ronnett GV, Snyder SH, (1993). Carbon monoxide: a putative neural messenger. Science 259: 381-384.
117. Vieira HL, Queiroga CS, Alves PM, (2008). Preconditioning induced by carbon monoxide provides neuronal protection against apoptosis. J Neurochem 107: 375-384.
118. Wainio WW, Greenless J, (1960). Complexes of cytochrome c oxidase with cyanide and carbon monoxide. Arch Biochem Biophys 90: 18-21.
119. Wang B, Cao W, Biswal S, Dore S, (2011). Carbon monoxide-activated Nrf2 pathway leads to protection against permanent focal cerebral ischemia. Stroke 42: 2605-2610.
120. Wick A, Wick W, Waltenberger J, Weller M, Dichgans J, Schulz JB, (2002). Neuroprotection by hypoxic preconditioning requires sequential activation of vascular endothelial growth factor receptor and Akt. J Neurosci 22: 6401-6407.
121. Williams SE, Wootton P, Mason HS, Bould J, Iles DE, Riccardi D, et al. (2004). Hemoxygenase-2 is an oxygen sensor for a calcium-sensitive potassium channel. Science 306: 2093-2097.
122. Xi Q, Tcheranova D, Basuroy S, Parfenova H, Jaggar JH, Leffler CW, (2011). Glutamate-induced calcium signals stimulate CO production in piglet astrocytes. Am J Physiol Heart Circ Physiol 301: H428-H433.
123. Yabluchanskiy A, Sawle P, Homer-Vanniasinkam S, Green CJ, Foresti R, Motterlini R, (2012). CORM-3, a carbon monoxide-releasing molecule, alters the inflammatory response and reduces brain damage in a rat model of hemorrhagic stroke. Crit Care Med 40: 544-552.
124. Yang H, Yang M, Guan H, Liu Z, Zhao S, Takeuchi S, et al. (2013). Mitochondrial ferritin in neurodegenerative diseases. Neurosci Res 77: 1-7.
125. Yao C, Wei G, Lu XC, Yang W, Tortella FC, Dave JR, (2011). Selective brain cooling in rats ameliorates intracerebral hemorrhage and edema caused by penetrating brain injury: possible involvement of heme oxygenase-1 expression. J Neurotrauma 28: 1237-1245.
126. Ye Z, Guo Q, Xia P, Wang N, Wang E, Yuan Y, (2012). Sevoflurane postconditioning involves an up-regulation of HIF-1alpha and HO-1 expression via PI3K/Akt pathway in a rat model of focal cerebral ischemia. Brain Res 1463: 63-74.
127. Yoo MS, Chun HS, Son JJ, Degiorgio LA, Kim DJ, Peng C, et al. (2003). Oxidative stress regulated genes in nigral dopaminergic neuronal cells: correlation with the known pathology in Parkinson's disease. Brain Res Mol Brain Res 110: 76-84.
128. Zeynalov E, Dore S, (2009). Low doses of carbon monoxide protect against experimental focal brain ischemia. Neurotox Res 15: 133-137.
129. Zeynalov E, Shah ZA, Li RC, Dore S, (2009). Heme oxygenase 1 is associated with ischemic preconditioning-induced protection against brain ischemia. Neurobiol Dis 35: 264-269.
130. Zhang F, Wang S, Zhang M, Weng Z, Li P, Gan Y, et al. (2012). Pharmacological induction of heme oxygenase-1 by a triterpenoid protects neurons against ischemic injury. Stroke 43: 1390-1397.
131. Zhuang H, Kim YS, Koehler RC, Dore S, (2003a). Potential mechanism by which resveratrol, a red wine constituent, protects neurons. Ann N Y Acad Sci 993: 276-286, discussion 287-8.
132. Zhuang H, Kim YS, Namiranian K, Dore S, (2003b). Prostaglandins of J series control heme oxygenase expression: potential significance in modulating neuroinflammation. Ann N Y Acad Sci 993: 208-216, discussion 287-8.
133. Zimmermann A, Leffler CW, Tcheranova D, Fedinec AL, Parfenova H, (2007). Cerebroprotective effects of the CO-releasing molecule CORM-A1 against seizure-induced neonatal vascular injury. Am J Physiol Heart Circ Physiol 293: H2501-H2507.
134. Zobi F, (2013). CO and CO-releasing molecules in medicinal chemistry. Future Med Chem 5: 175-188.
135. Zuckerbraun BS, (2008). Therapeutic delivery of carbon monoxide: WO2008/003953. Expert Opin Ther Pat 18: 1321-1325.
136. Zukor H, Song W, Liberman A, Mui J, Vali H, Fillebeen C, et al. (2009). HO-1-mediated macroautophagy: a mechanism for unregulated iron deposition in aging and degenerating neural tissues. J Neurochem 109: 776-791.